RxDoctor Payments Data

Jennifer Balint, PA

Medical · Berkley, MINPI 1417478025

Payments from drug & device makers

$821in general payments, 2019–2025

Across 40 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$242
  • Abbott$69
  • Boehringer Ingelheim$51
  • Corcept Therapeutics$49
  • Boston Scientific$48
  • Pfizer$42
  • plus $322 from 13 others

What the payments were for

  • Food & beverage$821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$821 in reported general payments places this provider in the 60th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Medicare billing

Part B allowed, 2024
$31,871
Medicare patients
130
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$38,755
OzempicSemaglutide28$28,656
JardianceEmpagliflozin25$26,228
TrulicityDulaglutide20$21,048
XareltoRivaroxaban29$20,679
MounjaroTirzepatide14$20,041
JanuviaSitagliptin Phosphate20$18,827
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$17,369
FarxigaDapagliflozin Propanediol18$15,223
Spiriva RespimatTiotropium Bromide12$10,596
Atorvastatin Calcium274$2,750
Albuterol Sulfate HfaAlbuterol Sulfate80$2,535
Metoprolol Succinate155$2,373
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,231
Losartan Potassium158$1,643

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$31$41,08934 claims
PfizerEliquis$42$38,75549 claims
Boehringer IngelheimJardiance, Spiriva Respimat$51$36,82437 claims
Novo NordiskOzempic$42$28,65628 claims
MerckJanuvia$25$18,82720 claims
GSKTrelegy Ellipta$35$17,36920 claims
AstraZenecaFarxiga$242$15,22318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 755 medical providers in Michigan.

Other medical in Berkley

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →